Mullein
*Verbascum densiflorum* / *V. thapsus*
Evidence Rating
Confidence Level
Traditions
Last Updated
Summary
Mullein flower (Verbasci flos) is a traditional European demulcent and expectorant herb used for centuries in the treatment of respiratory catarrh and cough. It holds Commission E approval for catarrhs of the respiratory tract and EMA traditional use registration as an expectorant in cough associated with cold, but is not covered by ESCOP. Its mucilage content (approximately 3%) provides a soothing demulcent effect on irritated mucous membranes, while saponins (verbascosaponin) contribute a mild expectorant action. Clinical trial evidence is essentially absent; approval rests almost entirely on longstanding traditional use and pharmacological plausibility. Mullein is frequently used in combination with other respiratory herbs such as thyme and marshmallow in European herbal tea blends.
Regulatory Status
| Regulatory Body | Status |
|---|---|
| Commission E (Germany) | âś“ Approved |
| ESCOP (European) | — |
| EMA/HMPC (EU) | âś“ Approved |
Metadata
| Field | Detail |
|---|---|
| Common Names | Mullein, Great Mullein, Königskerze (German), Bouillon blanc (French) |
| Botanical Name | Verbascum densiflorum Bertol. / Verbascum thapsus L. |
| Plant Family | Scrophulariaceae |
| Part Used | Flowers (Verbasci flos) |
| Key Constituents | Mucilage (~3%), saponins (verbascosaponin), iridoid glycosides (aucubin, catalpol), flavonoids (hesperidin, rutin), phenylethanoid glycosides (verbascoside/acteoside) |
| Major Standardized Extracts | None widely standardized; used primarily as herbal tea or in combination preparations |
| Evidence Quality Rating | D (Traditional use only) — Commission E and EMA approved; no RCTs; pharmacological rationale plausible but unconfirmed clinically |
Approved Indications
Commission E
- Catarrhs of the respiratory tract (Katarrhe der Luftwege)
ESCOP
- No ESCOP monograph exists for Verbascum densiflorum / V. thapsus
EMA/HMPC
- Traditional use: As an expectorant in cough associated with common cold
- Classification based on long-standing traditional use (not well-established use)
- EMA monograph covers Verbascum thapsus L., V. densiflorum Bertol., and V. phlomoides L.
Agreement/Disagreement Between Bodies
Commission E and EMA are broadly aligned on the respiratory catarrh/cough indication, though Commission E uses “catarrhs of the respiratory tract” while EMA specifies “expectorant in cough associated with cold.” ESCOP has not issued a monograph, which represents a gap rather than a disagreement. Neither body grants well-established use status, reflecting the absence of clinical trial evidence.
Conditions Treated
Primary
- Respiratory catarrh
- Cough associated with common cold (dry and productive)
- Upper respiratory tract irritation
Secondary
- Sore throat and pharyngeal irritation
- Mild bronchitis (traditional use)
Traditional/Historical
- Ear infections (mullein oil drops — traditional folk remedy, not covered by regulatory monographs)
- Skin inflammation and wound healing (external use of flowers)
- Hemorrhoids (folk medicine)
- Urinary tract complaints (folk medicine, not substantiated)
Mechanism of Action
1. Demulcent/Mucoprotective (Mucilage)
- Mucilage polysaccharides (~3% of dried flowers) form a protective film over irritated respiratory mucosa
- Shields sensory nerve endings from irritants, reducing the cough reflex
- Local/topical mechanism, not requiring systemic absorption
- Similar principle to marshmallow (Althaea officinalis) and plantain (Plantago lanceolata), though lower mucilage content
2. Expectorant (Saponins)
- Verbascosaponin and related triterpenoid saponins stimulate bronchial secretion via reflex mechanisms
- Increased mucus production helps hydrate viscous secretions, facilitating expectoration
- This provides a mild secretolytic effect complementary to the demulcent action
3. Anti-inflammatory
- Verbascoside (acteoside): Phenylethanoid glycoside with demonstrated anti-inflammatory and antioxidant activity in vitro
- Inhibits pro-inflammatory pathways including NF-kB
- Aucubin: Iridoid glycoside with anti-inflammatory and mild antimicrobial properties (also found in plantain)
4. Antimicrobial
- Verbascoside and saponins demonstrate mild antibacterial activity against respiratory pathogens in vitro
- Aucubin aglycone (aucubigenin) shows activity against Staphylococcus aureus
- Clinical relevance at therapeutic doses remains unconfirmed
Key Active Constituents
- Mucilage polysaccharides (~3%): Galactomannans, arabinogalactans
- Saponins: Verbascosaponin (triterpenoid type)
- Iridoid glycosides: Aucubin, catalpol (shared with plantain)
- Phenylethanoid glycosides: Verbascoside (acteoside), forsythoside B
- Flavonoids: Hesperidin, rutin, apigenin, luteolin glycosides
- Essential oil (traces)
Clinical Evidence Summary
Clinical Trial Evidence
- No randomized, placebo-controlled clinical trials have been identified for mullein flower monotherapy in respiratory conditions
- The Commission E and EMA approvals rely entirely on traditional use documentation and pharmacological plausibility
- This represents one of the weakest clinical evidence bases among respiratory herbs in this collection
Preclinical/In Vitro Evidence
- Anti-inflammatory activity of verbascoside confirmed in multiple in vitro models
- Antimicrobial activity demonstrated against selected respiratory pathogens
- Saponin-mediated secretolytic activity demonstrated in animal models
- Antioxidant activity of phenolic compounds confirmed
Traditional Use Evidence
- Documented use in European folk medicine for centuries
- Listed in numerous traditional European pharmacopoeias and herbals
- Mullein flower tea (Königskerzenblütentee) is a traditional component of breast/chest tea blends (Brusttee) in German-speaking countries
- Mullein oil (flowers macerated in olive oil) has a long folk tradition for earache, though this use is outside the scope of regulatory monographs
Evidence Assessment
The pharmacological rationale for mullein as a respiratory demulcent/expectorant is plausible based on its mucilage and saponin content, and the constituent verbascoside has demonstrable anti-inflammatory properties. However, the complete absence of clinical trial data means efficacy remains unproven by modern standards. The evidence gap is significant.
European vs US/Anglophone Consensus
| Aspect | Europe (esp. Germany) | US/Anglophone |
|---|---|---|
| Regulatory status | Traditional herbal medicine (OTC); Commission E and EMA approved | Dietary supplement; no regulatory therapeutic claims |
| Medical use | Component of traditional chest tea blends (Brusttee); available in pharmacies | Used in herbal/naturopathic practice; folk remedy for ear oil |
| Cultural status | Well-known as Königskerze; recognized medicinal plant | Known primarily to herbalists; folk remedy tradition exists |
| Evidence recognition | Accepted as traditional expectorant/demulcent | Not in any clinical guidelines; limited academic interest |
| Products | Herbal teas, combination respiratory preparations | Mullein leaf tea, mullein ear oil (folk remedy) |
| Part used emphasis | Flowers (Verbasci flos) per pharmacopoeial standards | Leaves more commonly used in Anglophone herbal tradition |
Notable difference: European pharmacopoeial tradition emphasizes the flowers (Verbasci flos), while Anglophone herbal tradition more commonly uses leaves. The regulatory monographs (Commission E, EMA) specifically cover the flowers.
Safety Profile
Contraindications
- Hypersensitivity to Verbascum species or other Scrophulariaceae
- No other contraindications known
Drug Interactions
- No known drug interactions documented
- No clinically significant interactions expected based on pharmacological profile
Side Effects
- Very rare at therapeutic doses
- Minor gastrointestinal discomfort possible but uncommon
- Contact dermatitis from handling fresh plant material reported rarely
- Very good safety profile overall
Pregnancy/Lactation
- Pregnancy: No specific safety concerns identified from traditional use. However, formal safety studies are lacking. EMA monograph does not recommend use during pregnancy due to insufficient data.
- Lactation: Insufficient data. EMA monograph does not recommend use during breastfeeding due to lack of safety data.
- Not recommended for children under 12 years (EMA) due to insufficient data, though traditional use in children has occurred without reported problems.
Clinical Dosage
Herbal Tea (Infusion)
| Preparation | Dosage | Notes |
|---|---|---|
| Dried flowers | 1.5-2 g per cup | Standard single dose |
| Infusion | Pour 150 mL boiling water over 1.5-2 g dried flowers; steep 10-15 minutes, strain through fine cloth | Filter through cloth or fine sieve to remove irritating staminal hairs |
| Daily dose | 3-4 g dried flowers | Divided into 2-3 cups daily |
Other Preparations
| Preparation | Dosage |
|---|---|
| Fluid extract (1:1) | 1-2 mL, 3 times daily |
| Tincture (1:5 in 25% ethanol) | 3-5 mL, 3 times daily |
Preparation Notes
- Important: Mullein flower infusions must be strained carefully through a fine cloth or paper filter to remove fine staminal hairs, which can cause throat irritation if ingested
- Often used in combination with thyme, marshmallow, plantain, or mallow in traditional chest tea blends
- For cough: Drink warm, several times daily
Duration
- Acute use: 7-14 days for cough associated with cold
- If symptoms persist beyond 7 days, medical consultation is recommended (EMA)
Sources
- German Commission E Monograph: Verbasci flos
- EMA/HMPC Community Herbal Monograph on Verbascum thapsus L., V. densiflorum Bertol., V. phlomoides L., flos
- EMA/HMPC Assessment Report on Verbascum thapsus L., V. densiflorum Bertol., V. phlomoides L., flos
- European Pharmacopoeia: Verbasci flos monograph
- Turker AU, Camper ND. Biological activity of common mullein, a medicinal plant. J Ethnopharmacol. 2002;82(2-3):117-125
- Slagowska A, et al. Qualitative and quantitative analysis of phenolic compounds in Verbascum densiflorum and V. phlomoides. Planta Med. 2000
- Arzneipflanzenlexikon: Verbascum densiflorum (arzneipflanzenlexikon.info)
- Wichtl M (ed). Herbal Drugs and Phytopharmaceuticals. 3rd ed. Stuttgart: Medpharm; 2004
Connections
- Compare demulcent mechanism with Marshmallow (Althaea officinalis — higher mucilage content, stronger demulcent)
- Shares iridoid glycoside constituents (aucubin, catalpol) with Plantain (Plantago lanceolata)
- Often combined with Thyme in European chest tea blends for productive cough
- Compare with Ivy Leaf for expectorant action (ivy leaf has much stronger clinical evidence)
- Compare traditional use evidence level with Linden Flower (both primarily traditional use category)
Related Herbs
Ivy Leaf
Hedera helix
Ivy leaf extract is one of the best-evidenced herbal expectorants in European phytotherapy. The standardized extract EA 575 (marketed as Prospan) has been studied in over 65,000 patients across clinical and observational studies. It has a well-characterized molecular mechanism involving indirect beta-2 adrenergic receptor stimulation via the saponin alpha-hederin. It holds approvals from all three major European regulatory bodies (Commission E, ESCOP, EMA/HMPC) and is widely used in pediatric practice.
Linden / Lime Flower
Tilia spp.
Linden flower (Tiliae flos) is one of the most traditional European remedies for feverish colds, used for centuries as a diaphoretic "sweat cure" herb. It has Commission E, ESCOP, and EMA/HMPC approval, but its evidence base is almost entirely from traditional use rather than clinical trials. No meaningful modern RCTs exist. Its diaphoretic mechanism is attributed to flavonoids (quercetin, kaempferol) and phenolic acids. It remains very popular as a home remedy tea in German-speaking countries. There is a notable safety concern: the German Commission E monograph mentions potential cardiotoxicity, though this is contested and may apply only to excessive doses.
Marshmallow
Althaea officinalis
Marshmallow root is one of the oldest and most respected demulcent herbs in European phytotherapy, specifically indicated for dry irritative cough and mucous membrane irritation. It holds Commission E, ESCOP, and EMA/HMPC approval. Its mechanism -- bio-adhesive mucilage polysaccharides forming a protective film on irritated mucosa -- is well-understood and pharmacologically elegant. Clinical evidence includes a large consumer survey (n=822) demonstrating rapid symptom relief, but large placebo-controlled RCTs are lacking. The standardized extract STW 42 (Phytohustil) is the most studied preparation.